valu histamin h2receptor antagonist manag patient zollingerellison syndrom	inhibit acid secret h2receptor antagonist metiamid assess three patient zollingerellison syndrom metiamid inhibit acid secret transient hour per cent patient although anticholinerg drug alon inhibit acid secret per cent patient combin metiamid anticholinerg mark prolong inhibitori effect metiamid total gastrectomi refus one patient imposs anoth treat metiamid anticholinerg five month third patient treat metiamid anticholinerg three week prepar total gastrectomi ulcer pain diarrhea disappear gain weight h2receptor antagonist may use treatment patient zollingerellison syndrom	D015043
zollingerellison syndrom treat medic inhibitor histamin receptor	metiamid histamin h2receptor antagonist use treat case zollingerellison syndrom character long stand diarrhea import gastric hypersecret moderat elev plasma gastrin without digest ulcer dose per day metiamid induc complet suppress acid secret effect last day stop drug accord sinc find time laparotomi small lymph node enlarg endocrin metastat tissu stomach left intact metiamid pursu first month chronic administr metiamid acid secret maintain level pcent initi valu ulterior howev although dosag metiamid increas acid hypersecret resum duoden ulcer develop total gastrectomi perform month begin metiamid spite failur metiamid treatment long term follow case zollingerellison syndrom allow get theoret practic inform	D015043
bioluminesc assay enzym obtain buccal epithelium superfici scrape	method present simultan assay buccal enzym measur reduc nicotinamid adenin dinucleotid adenosin triphosph aid bioluminesc luciferas extract activ glucose6phosph dehydrogenas g6pdh shown earlier increas homogen leukoplakia oral mucosa sinc smoke implic etiolog factor leukoplakia g6pdh measur normal buccal epithelium cigarett smoker differ found activ g6pdh smoker nonsmok relat activ pyruv kinas known invari healthi leukoplak oral mucosa new compact kinet luminesc analyz briefli describ	D007972
pictur frame fibr carrier trait malign hyperpyrexia	member famili known suscept malign hyperpyrexia identifi carrier presenc elev serum creatinephosphokinas investig muscl examin biochem studi includ sarcoplasm atpaseact actinomycin mg2 atpas activ atp phosphocreatin glucose6phosph addit calcium uptak sarcoplasm reticulum studi histochem analysi muscl reveal presenc new fibr type characteris dens rim atpas activ give impress picturefram ultramicroscop studi reveal chang mitochondria area myofibrillar disrupt swell sarcoplasm reticulum	D009369
hepatomaassoci alkalin phosphatas kasahara isozym compar one isozym amnion cell	found human hepatomaassoci alp orthophosphor monoest phosphohydrolas share electrophoret mobil inactiv urea inhibit inorgan phosphat ethylenediaminetetraacet amino acid lphenylalanin lleucin lhomoarginin heat stabil sensit neuraminidas optimum valu antigen site fast move alp isozym cell strain deriv human amniot membran howev 40weekold fresh amniot membran lack isozym instead placent type alp consist minor compon alp isozym cell properti common hepatoma alp regard lphenylalanin sensit inhibit ethylenediaminetetraacet inactiv urea antigen site differ electrophoret mobil sensit lleucin lhomoarginin presenc anoth antigen site heat stabl sensit inhibit inorgan phosphat hepatoma possibl regulatori mechan hepatomatyp alp placent type alp amnion cell consid	D006528
stearoylcoa desaturas activ mammari adenocarcinoma carri c3h mice	transplant mammari adenocarcinoma liver c3h mice fed stock diet linol rich diet corn oil contain similar amount oleat mggm tissu feed either high carbohydr fat free high carbohydr satur fatcontain hydrogen coconut cottonse oil diet week oleat level increas 2fold tumor 5fold liver specif activ stearoylcoa desaturas liver microsom similar correspond fraction mammari gland lactat mice liver activ enhanc 3fold feed high carbohydr fat free high carbohydr satur fat diet desaturas activ mammari tumor microsom hepat microsom remain unalt regardless type diet fed observ suggest major portion oleat mammari tumor produc within tissu dietari adapt general characterist stearoylcoa desaturas neoplast tissu enhanc desaturas activ liver direct relat absenc linol oleat larg decreas oleat diet	D000230
isol character unsatur fatti acidrequir mutant cultur mammalian cell	unsatur fatti acidrequir mutant deriv chines hamster ovari cho cell isol character mutant grow normal oleat unsatur fatti acid supplement growth medium unlik wildtyp cho cell growth stop medium depriv unsatur fatti acid whole cell puls experi 14cacet 14cstearat indic mutant defect unsatur fatti acid synthesi enzym assay vitro show enzymat defect mutant local microsom stearoylcoa desaturas	D010051
acidbas balanc amphibian gastric mucosa	establish secret maintain frog stomach absenc exogen co2 use nutrient bath fluid contain h2po4 approxim equal lower nonbuff nutrient solut exogen co2 presenc nutrient solut uniform caus mark decreas secret adn shortcircuit current isc increas transmucos resist elev nutrient reduc signific transient without chang nutrient less wherea return base line increas nutrient greater acidif nutrient medium presenc exogen co2 result inhibit secretori pump probabl decreas intracellular also interfer conduct nutrient membran remov exogen co2 standard bicarbon nutrient solut reduc isc without chang kfree nutrient solut revers chang isc drop rise induc kfree nutrient solut co2 return toward normal find support import role exogen co2 maintain normal acidbas balanc frog mucosa act acidifi agent	D013274
circul level prolactin human breast cancer	serum prolactin concentr measur radioimmunoassay patient establish carcinoma breast patient cystic mastiti patient gynaecomastia compar age match normal control women serum prolactin level patient breast cancer gynaecomastia cystic mastiti observ similar normal women interest note level prolactin luteal phase cycl higher earli follicular phase normal women	D001943
laboratori aid diagnosisenzym	summari present organ specif enzym assay tradit use evalu patient cancer addit use certain serum enzym gammaglutamyl transpeptidas phosphohexos isomeras 5nucleotidas aid follow cours diseas particular patient metastat spread liver outlin also consid util enzym analysi biopsi tissu biolog fluid wash bodi caviti newer enzym consid might futur develop diagnost tool probe understand etiolog cancer	D009369
optim semiautomat rate method serum glutathion reductas activ applic patient malign diseas	improv optim method serum glutathion reductas describ refer rang normal subject iu1 method sensit convent enzym test detect malign diseas rais frequent patient clinic evid metastas clinic free metastas seem correl prognosi among patient fail surviv six month time analysi first conduct	D009362
ornithin decarboxylas activ dna synthesi morri hepatoma 5123c		D006528
cimetidin suppress nocturn gastric secret activ duoden ulcer	nocturn pain gastric hypersecret common duoden ulcer therefor investig antisecretori effect new h2receptor antagonist cimetidin 400mg dose taken oral bedtim 200mg dose caus statist signific chang nocturn midnight acid output borderlin effect howev 300mg 400mg dose signific less lower acid output increas less intragastr dose caus substanti decreas secretori volum output 400mg dose half patient remain anacid eight hour doserel increas drug blood level observ correl degre durat inhibit acid output serum gastrin level unaffect cimetidin appear potent inhibitor nocturn gastric secret	D013274
electronmicroscop studi graviti receptor ctenophor	secondarili sensit receptor balanc cell compris graviti receptor abor organpolival organ ctenophora ctenophora phylogenet first anim creat receptor cell suppli singl flagellar kinocilium connect otolith apparatus receptor balanc cell innerv nerv fiber branch nerv cell abor ganglion local ach buch product cytochem reaction sodium suggest cholinerg mechan may take part process synapt transmiss morpholog data cannot exclud adrenerg mechanizm also	D045888
multipl endocrin adenomatosi syndrom	mea two genet distinct tumor endocrinopathi show autosom domin inherit littl overlap exist condit present explain basi two mutual exclus factor secondari consequ hormon excess anoth endocrin gland fact tumor syndrom appear result genet faulti differenti neuroectoderm seem disproportion amount effort expend studi mea syndrom howev would seen ampl justif interest mea syndrom unlik neoplast condit hereditari readili detect expediti treat hormon radioimmunoassay great facilit diagnosi asymptomat individu probabl import studi syndrom provid consider insight embryolog origin endocrin system conceiv knowledg gain condit may stimul inquiri process wherebi neoplasia occur endocrin tissu thus lead way develop effect therapi host hormoneproduc tumor	D018761
letter iga level cancer patient		D009369
evalu lipas activ serum radial enzym diffus	result determin serum lipas radial enzym diffus correl well titrimetr refer method abnorm rang specif diffus assay allow differenti patient pancreat diseas even lipas activ serum within normal limit tritrimetr assay pancreat lipas detect diffus assay serum individu free pancreat diseas	D010190
protein hepatoma tissu cultur cell plasma membran	specif lactoperoxidasecatalyz iodin protein hepatoma tissu cultur cell plasma membran examin histochem biochem cell fraction techniqu light microscop autoradiographi section cell show incorpor label local primarili peripheri cell label releas cell trypsin collagenas hyaluronidas label recov cell either monoiodotyrosin diiodotyrosin hydrolysi cell extract mixtur proteolyt enzym label copurifi cell fraction authent liver cell plasma membran marker enzym 5nucleotidas thus incorpor iodid valid marker membran polypeptid tyrosin residu access lactoperoxidas polypeptid complex purifi plasma membran examin high resolut dodecyl sulfatepolyacrylamid gel electrophoresi least polypeptid membran access iodin polypeptid probabl repres bulk protein mass membran iodin affect cell viabil growth rate cell function label experi fucos glucosamin show least nine iodin peptid may glycoprotein	D006528
viabil cell ethanol role alcohol dehydrogenas	rodent cell found contain high level alcohol dehydrogenas activ induc hepatoma nonhepatoma cell line test found contain lower measur level alcohol dehydrogenas	D006528
differ number insulin bind site cortisolsensit cortisolresist lymphoma p1798 cell	cortisolsensit cortisolresist lymphoma p1798 cell specif bind 25iinsulin resist lymphocyt bind less insulin sensit cell result suggest insulin insulinlik substanc may play role growth regul andor respons tumor glucocorticoid therapi	D009369
serum gammaglutamyl transpeptidas activ metastat liver carcinoma liver diseas		D008113
letter diagnosi renal tumor gammaglutamyltranspeptidas		D007680
studi chemic natur urinari chemiluminesc	studi natur chemic respons urinari chemiluminesc carri urinari chemiluminesc increas slight sulphatas glucuronidas boil hour suggest chemic respons urinari chemiluminesc bound nonchemiluminesc precursor sulphat glucuron acid way chemiluminesc materi inact precursor freeli ultrafiltr molecular weight survey various chemic reveal consider chemiluminesc certain metabolit naphthylamin known caus bladder cancer littl chemoluminesc tryptophan metabolit thought caus bladder cancer	D001749
suppress stimul mechan control glucagon secret case isletcel tumor produc glucagon insulin gastrin	mechan control secret glucagon pancreat hormon studi patient affect multihormonesecret isletcel tumor fast glucagon level pgml rose ngml follow arginin stimul oral glucos load intraven glucos infus suppress glucagon secret insulin administr induc prompt depress glucagon level glucagon insulin gastrin level suppress somatostatin calcium infus caus paradox increas suggest stimulationinhibit mechan conserv case glucagonsecret pancreat tumor	D010190
bile canalicular alkalin phosphatas diseas	alkalin phosphatas reaction normal absent human bile canaliculi found patient search common causal factor patient examin thirtyseven autopsi condit ocmmon associ phenomenon malign tumour without involv liver collagen diseas longstand partial obstruct common bile duct genet variant alpha1antitrypsin clinic laboratori fact common patient	D009369
inhibit newcastl diseas virus replic 6azauridin inefficaci purifi uridin kinas effect adenosine5triphosph	distinct cellfre extract prepar tumour cell partial purifi uridin kinas prepar cell effect 6azauridin azurd inhibit newcastl diseas virus ndv replic show uridin kinas effect compon cellfre extract adenosine5triphosph atp found exert synerg effect combin azurd inhibit ndv replic	D009369
amino acid stimul atp cleavag two ehrlich cell membran prepar presenc ouabain	two membran fraction prepar ehrlich ascitestumor cell show nonident stimulatori respons certain amino acid mg2 depend activ cleav atp despit presenc ouabain absenc first previous describ show littl katpas activ characteristicallli stimul presenc certain diamino acid low pk2 valu suggest cation form amino acid effect evid indic effect obtain occup kinet discern receptor site serv characterist uphil transport amino acid ehrlich cell second membran prepar purifi goal concentr katpas activ also stimul model diamino acid 4amino1methylpiperidine4carboxyl acid sever ordinari amino acid diamino acid effect valu neutral zwitterion form might respons among optic activ amino acid test effect ornithin leucin substanti stronger isom list stimulatori amino acid correspond poor singl transport system although possibl exclud stimul might occur prepar occup membran site ordinarili kinet silent transport sequenc high sensit deoxychol dicyclohexylcarbodiimid hydrolyt activ produc presenc lornithin 4amino1methylpiperidine4carboxyl acid suggest stimulatori effect mere general intensif background depend hydrolyt activ	D009369
studi human transcortin differ phs circular dichroism polymeris bind affin	transcortin use work extrem pure shown polymeris observ polymeris never observ impur form transcortin moreov sinc known presenc cortisol bind site essenti condit activ purifi transcortin appear correl secondari structur biolog activ transcortin exist result obtain summar inhibit transcortin bind capac essenti take place reorganis structur protein moieti observ decreas helic ratio observ appear therefor limit experiment accuraci measur determin amount betastructur appreci chang bind activ take place appear larg percentag betastructur hand sudden decreas protein activ low like correl disappear welldefin helic region biochem physic experi would cours necessari order precis first observ structurefunct relationship transcortin	D006223
synthet mif effect betamsh acth hypersecret nelson syndrom	effect synthet mif hproleuglynh2 betamsh secret studi five patient nelson syndrom one patient addison diseas two milligram tripetid inject intraven acut inject follow 30minuteinfus salin solut consist effect could observ 90minut period begin infus patient lvp stimul dexamethason suppress test brought signific chang plasma betamsh acth level	D009347
histamin metabol thinlay radiochromatograph assay histaminas histidin decarboxylas enzym activ	thinlay radiochromatograph method measur histaminas histidin decarboxylas activ develop assay specif respect enzym sensit reproduc perform use commerci avail substrat histaminas assay permit determin enzym activ mul pregnanc sera human granulocyt microgram quantiti partial purifi human placenta histaminas error less per cent histidin decarboxylas assay permit measur nanogram quantiti newli form histamin rat periton mast cell rat basophil leukemia cell error less per cent	D015471
radioreceptor assay prolactin		D001943
isol partial pepsin digest three collagenlik region present subcompon clq first compon human complement	digest human subcompon c1q pepsin ph445 20h degre fragment noncollagenlik amino acid sequenc molecul small peptid wherea entir region collagenlik sequenc compris weight subcompon c1q left intact collagenlik fraction digest elut void volum sephadex g200 column showm compos two major fragment examin electrophoresi polyacrylamid gel run buffer contain sodium dodecyl sulphat fragment separ cmcellulos ph49 buffer contain 75murea human subcompon c1q reduct alkyl yield equimolar amounnt three chain design reid biochem one pepsin fragment shown compos ntermin residu chain link via residu singl disulphid bond residu sequenc b2b6 ntermin residu chain second pepsin fragment shown compos disulphidelink dimer ntermin residu chain disulphid bond locat residu c44 mol wts unoxid oxid pepsin fragment estim amino acid composit dimer collagenlik fragment chain respect estim molecular weight peptic fragment polyacrylamidegel electrophoresi run presenc sodium dodecyl sulphat gave valu approx higher expect amino acid sequenc data probabl due high collagenlik sequenc content fragment	D018365
radiationinduc xerostomia cancer patient effect salivari serum electrolyt	saliva serum electrolyt concentr monitor patient given cours xerostomiaproduc cancer radiotherapi mean flow rate stimul whole saliva decreas 6week treatment period strike reduct saliva output accompani signific increas saliva prot concentr decreas saliva hco3 content xerostom saliva concentr greater salin pretreat saliva instanc contrast none serum electrolyt measur signific alter subtot salivari shutdown	D009369
amino acid transport isol neuron glia	effort direct toward character amino acid uptak metabol releas bulkisol glia neuron perikarya studi parallel nerveend especi concern transmitt amino acid particip glia clear synpat space impuls conduct possibl neuromodul role glia synaps also suggest kstimul releas definit conclus base far studi gaba although also begin accumul data glutam relat glutamateglutamin compartment glia preferenti accumul potassium amino acid compar neuron perikarya higher nakatpas activ possess highaffin sodiumdepend uptak system gaba glutam similar one synaptosom releas amino acid respons potassium puls calciumindepend process low neuron uptak could due loss dendrit unidirect gabaflux synaptosom glial compart support high gad nerv end compar high gabat glia glutamin may transmitt glutamateprecursor nerveend sinc glutaminas activ high nerveend low glia glutamin presum made glutamin uptak glia synaptosom obey lowaffin kinet contrast glutam consist inabl glutamin excit neuron membran studi gaba consider extens support relat work use glia tissuecultur autoradiographi appear suggest differ behavior amin poor taken glial system glia synaptosom neuron perikarya general behav similar respect requir uptak releas except case exert opposit effect glial synaptosom uptak gaba believ work along line tend firm establish direct role glial cell modul neuron excit repres converg transmitt amino acid neuropharmacolog cellular biochemistri deepen enlarg vocabulari synapt biochemistri also undoubt major clinic applic field epilepsi behavior	D015458
gastric extragastr gastrin releas normal subject duoden ulcer patient patient partial gastrectomi billroth	normal subject patient duoden ulcer patient partial gastrectomi billroth serum gastrin rose signific oral intraduoden test meal highest increas observ patient oral well intraduoden test meal intraduoden test meal normal subject patient increas gastric acid secret serum gastrin measur basal state intraduoden oral test meal patient normal gastric acid secretori capac higher serum gastrin concentr patient gastric hypersecret good correl peak serum gastrin level oral intraduoden test meal data conclud intraduoden applic test meal result releas gastrin extragastr site extragastr gastrin biolog activ patient abl releas antral extragastr gastrin respons test meal studi howev necessari show signific find pathogenesi peptic ulcer diseas	D013274
identif breast cancer transcortin inhibitori role cellmedi immun		D001943
statist analysi cerebrospin fluid acidbas equilibrium cerebrospin fluid lactat concentr case brain tumor cerebrocrani injuri meningoenceph	statist analysi csf lactat concentr csf pco2 perform valu obtain sampl taken neurosurg patient valu pco2 classifi three group correspond follow three rang lactat concentr mean valu standard deviat calcul suitabl test student cochran cox use establish statist signific chang csf acidbas balanc present lactat level next patient lactat concentr analys divid three group accord etiolog inflammatori chang injuri tumour shown csf acidbas balanc patient brain tumour less disturb patient inflammatori chang brain injuri	D001932
letter gamma glutamyltranspeptidas tumor patientsexperi hungari		D009369
influenc acid secretori state gastric mucos toler back diffus	effect back diffus pon potenti differ electr resist short circuit current isc spontan secret burimamideinhibit amphibian gastric mucosa studi vitro back diffus induc passag electr current mua per cm2 secretori side nutrient side min spontan secret mucosa show small decreas lead isc lead mua per cm2 signific chang burimamideinhibit mucosa mark signific greater decreas lead lead ohm cm2 isc lead mua per cm2 back diffus induc establish concentr gradient lead expos secretori surfac sodium taurochol secretori burimamideinhibit tissu demonstr signific greater depress electr paramet secret mucosa intracellular measur 55dimethoxyazolidine24dion method signific higher histaminestimul tissu metiamideinhibit tissu studi strong suggest secretori status mucosa henc acidbas status import determin toler tissu exogen back diffus measur absolut loss mucos solut alon may adequ assess gastric mucos barrier	D013274
phosphohexos isomeras use paramet manag neoplasia		D009369
interact tropomyosin troponin compon	tnt tni compon troponin interact tropomyosin caus precipit kc1 neutral precipit contain endtoend sidebysid aggreg tropomyosin molecul tnt tni compon chang band pattern tropomyosin paracryst form mgc12 solut although differ way tnt caus format hexagon net structur doublestrand net paracryst result collaps doublestrand net tni caus format paracryst period band pattern repeat band pattern also seen tropomyosin paracryst form valu tnc compon precipit tropomyosin kc1 aggreg tropomyosin obtain either tnt tni solubil addit tnc interact tnc observ tropomyosin paracryst form presenc mgc12	D015458
critic observ chang gammaglutamyltranspepdidas hepatopathi	behaviour gammaglutamyl transpeptidas compar serum enzym activ function paramet care select relat extens seri patient liver diseas includ alcohol investig under pathogenesi clinic express refer literatur person data show increas gammaglutamyl transpeptidas level could attribut enzym induct caus drug alcohol liver damag broad sens intra extrahepat cholestasi caus individu predomin near occas though concomit common high level howev pathognomon given diseas alcohol high indic especi accompani gld chang virtual constant earli typic find intra extrahepat cholestasi tend persist time resolut icterus last aid earli diagnosi aggress hepat liver cancer	D008113
measur pituitari hormon clinic applic prolactin	sensit specif assay human prolactin develop use human prolactin antiserum distribut unit state nation pituitari agenc plasma prolactin concentr control subject rang ngml sex differ prolactin concentr observ brisk increas plasma prolactin level occur normal subject administr chlorpromazin thyroid stimul hormon releas factor trh stimulatori test prolactin releas therefor use assess hypothalam pituitari function basal plasma prolactin valu rais patient treat phenothiazin help diagnost patient amenorrhoea galactorrhoea hypogonad craniopharyngioma nonfunct pituitari tumour acromegali mani disord signific reduct plasma prolactin concentr observ follow oral administr bromocriptin plasma prolactin determin use evalu respons medic treatment pituitari ablat	D009369
polynucleotid synthesi properti poli 2azido2deoxyadenyl acid	poli 2azido2deoxyadenyl acid poli synthes 2azido2deoxyadenosin diphosph polynucleotid phosphorylas poli absorpt properti similar poli hypochrom neutral curv also resembl poli smaller ellipt titrat poli hcl gave transit exact structur acidform complex elucid upon mix poli poli form complex tms somewhat higher poli poli complex condit	D006223
disord induc pheochromocytoma cardiovascular system therapeut approach	diagnosi pheochromocytom still made post mortem high percentag case import know divers clinic form case investig present perman case paroxysm attack follow collaps one case paroxysm normotens background sever cardiovascular accid increas twofold crise arrhythmia left ventricular failur coronari insuffici cerebrovascular stroke secondari adrenalin shock complic preced alarm syndrom preoperatori treatment associ block adrenerg alphareceptor betareceptor correct hypovolemia also appli surgic phase venous ligatur made tumor excis continu monitor ecg abp central venous pressur phase vasoplegin prompt correct corticoid	D010673
b12 depend methionin synthetas potenti target cancer chemotherapi		D009369
sialyltransferas human malign melanoma	glycosyltransferas cmpnacetylneuramin acid glycoprotein sialyltransferas found human malign melanoma activ measur desial glycoprotein exogen acceptor enzym character mean optimum temperatur optimum degre valu mum sugar nucleotid desial glycoprotein requir exogen ad metal ion slight stimul mg2 requir deterg optim activ effect nucleotid sugar nucleotid enzym activ investig	D008545
betaglucuronidas oestrogen hydatidiform mole	activ betaglucuronidas betadglucuronid glycuronohydrolas placent hydatidiform mole tissu sera nonpregn normal molar pregnant women determin oestrogen concentr two solid tissu also assay signific differ found activ enzym placent molar tissu among various sera lower activ molar serum correspond lower concentr oestrogen molar tissu may regard respons allevi conjug requir	D006828
histamin h2receptor antagonist gastric acid secret progress report	histamin h2receptor antagonist includ burimamid metiamid cimetidin effect antagonist histaminestimul acid secret mammalian avian reptilian gastric mucosa acid secret stimul gastrin pentagastrin also inhibit drug disagr effect drug acid secret result activ acetylcholin receptor base pharmacolog evid possibl treatment drug discuss case excess stimul acid secret due high blood level histamin gastrin posit result sever trial zollingerellison syndrom peptic ulcer impress practic problem still solv exampl appropri phase appli drug demonstr clinic effect howev peptic ulcer offer clear altern surgeri mani patient	D015043
gingiv crevicular fluid new diagnost aid manag periodont patient	whole studi gcf demonstr flow fluid suffici indic inflammatori state use varieti clinic condit monitor control gingiv inflamm sinc gingiv extrem common sinc case gingiv presum progress periodont question could pose whether concert effort control inflamm tri achiev gcf flow near zero possibl would clinic signific evid contrari answer must yes sinc case known periodont occur without preced gingiv word control gingiv feasibl prevent case periodont although control gingiv would mean treatment mani case would progress periodont breakdown effort would worthwhil periodont destruct prevent even earli destruct lesion exhibit littl inflamm may soon identifi main minut volum fluid collect gingiv crevic measur accur accord concentr various constitu gcf determin lead develop test differenti pocket undergo activ destruct minim inflamm major activ lesion intim involv frank inflamm thus clinician would measur subclin gingiv inflamm measur gcf flow differenti destruct quiescent lesion analyz gcf sampl constitu chemic microbi listgarten indic periodont destruct process monitor flow gcf might valu clinic situat exampl one could monitor respons gingiv tissu various restor prosthet procedur strauss ensur procedur aggrav periodont tissu induc gingiv periodont educ patient easier sinc patient read number gcf meter examin selfevalu person periodont condit effect home care even educ dental student easier sinc would mean selfevalu effect treatment depend upon subject assess effort instructor final monitor gcf various compon could provid dentist valuabl mean easili screen patient system diseas obvious area investig infanc promis excit futur oral diagnostician	D034721
aryl hydrocarbon hydroxylas 16alphahydroxylas cultur human lymphocyt	aryl hydrocarbon hydroxylas 16alphahydroxylas examin intact cultur human lymphocyt two microsom mixedfunct oxygenas differ optima show competit inhibit enzym induct activ popul distribut lognorm enzym give appar evid polygen control induc level ahh slight higher among firstord relat lung colon cancer patient control group correl coeffici ahh sah coinduc indic correl suggest absenc associ two enzym man	D003110
involv protein synthesi posttransl control glutamin synthetas activ cultur hepatoma cell		D006528
relationship serum gastrin calcium concentr patient multipl endocrin neoplasia type	relationship serum gastrin calcium concentr examin patient multipl endocrin neoplasia type variat gastrin concentr induc metiamid secretin calcium concentr alter parathyroidectomi calcium infus chang serum gastrin concentr accompani chang serum calcium concentr howev alter serum calcium accompani signific parallel chang serum gastrin conclud acut chang serum calcium may induc chang serum gastrin parathyroidectomi patient produc fall serum gastrin abil produc larg quantiti gastrin remain postul thyroparathyroid hormon may modul relationship calcium gastrin	D018761
microdos mammographi	ten thousand mammogram perform daili unit state accumul radiat biolog data suggest approxim 90rad level radit breast incid cancer may increas microdos system roentgenographi describ provid better imag onethird onefifth exposur common use lowdos system oneeight onetenth dose xeromammographi system allow repeat xray studi patient requir without exceed critic level	D009369
synthesi alpha subunit human chorion gonadotrophin presumpt hela cell	sever cell line origin thought deriv human placenta term possibl helacontamin studi cell secret protein indistinguish immunochem alpha subunit chorion gonadotropin beta subunit chorion gonadotropin placent lactogen complet chorion gonadotropin detect amount less level alpha subunit cell also produc alkalin phosphatas similar placent alkalin phosphatas immunochem gelelectrophoret heatdenatur properti induc tumor growth inocul nude mice cell aneuploid model chromosom number common hela karyolog marker design atyp glucose6phosph dehydrogenas present cell hela cell previous shown secret alpha subunit hcg	D009369
serum gammaglutamyl transpeptidas activ diseas hepatobiliari system		D034721
prolactin male reproduct	prolactin prl peptid hormon hypophysi becom interest sinc determin radioimmunassay releas prolactin control two yet identifi factor prolactinreleasingfactor prolactininhibitingfactor latter predominant mani pharmacolog substanc alter releas normal serum level man ngml prolactin affect mani organ kidney mamma ovari testi hepar skin clinic test rais serum level tsh chlorpromacin drop applic 2bromalphaergocryptin use increas serum level found patient prolactinproduc tumor male follow disturb sexual potenc relat prolactin male infertil gynecomastia yet known	D009369
recent studi identif prolif abnorm oncogen potenti cutan cell individu increas risk colon cancer	recent studi describ growth characterist acr skin fibroblast cultur differenti suscept transform kirsten murin sarcoma virus kimsv deriv normal appear subepidermoid biopsi acr individu progeni ocntrol normal contactinhibit grew fcs acr subject asymptomat acr progeni contact inhibit grew fcs consider suscept transform kimsv control viral transform show loss anchorag depend methylcellulos form tumor athym mice result suggest presenc earli previous undetect metabol lesion clinic asymptomat subject phenotyp marker current evalu util clinic diagnosi individu latent acr increas risk colon cancer acr individu recent shown contain signific alter intracellular distribut actin pollack kopelovich prepar elev level plasminogen activ kopelovich	D003110
glucos 6phosphatedepend bind hexokinas membran ascit tumor cell	phdepend satur bind hexokinas isozym ehrlich ascit carcinoma plasma membran microsom prepar tissu demonstr bind enhanc glucos 6phosphat may consid sum glucos 6phosphatedepend bind independ bind half satur concentr hexokinas unit per type bind maxim bind unit per membran protein observ although optimum independ bind lower depend bind half satur concentr glucos 6phosphat requir depend bind 2deoxyglucos 6phosphat compet revers effect glucos 6phosphat bind diminish inhibit hexokinas activ	D002277
mechan reassembl immunoglobulin	noncoval interact light chain heavi chain isol human myeloma protein igg1 kappa studi follow circular dichroic chang dimer constant jol chain determin measur chang protein concentr show jol chain exist monomer form experiment condit use recombin chain secondord rate constant interact chain good agreement interact chain various valu bind behavior chain could describ singl associ constant interpret bind chain chain howev necessari assum bind chain one two site chain dimer decreas affin site chain bind constant first chain chain renatur process chain fabss fragment intact interchain disulfid bond fabra fragment interchain disulfid bond reduc alkyl denatur state acet acid neutral studi renatur occur rapid chain consist rapid process slow process follow firstord kinet renatur process fabss consist rapid slow phase latter follow firstord kinet renatur process fabra also consist rapid slow phase latter process follow secondord kinet overal rate constant renatur fabra reform fabra isol chain basi fact kinet mechan chain recombin yield fabra describ term scheme equilibrium lead fabra intermedi chang observ second unimolecular process first bimolecular process	D009101
studi interact damino acid oxidas quasisubstr	studi interact damino acid oxidas quasisubstr benzoat paminobenzo visibl circular dichroism spectra spectra measur bind rate affin oaminobenzo enzym observ follow absorpt chang various wavelength found new band around correspond chargetransf complex result format aminobenzo complex enzym ellipt band posit paminobenzo complex negat maminobenzo complex crossov point spectra observ maminobenzo complex oaminobenzo complex probabl result overlap posit band fad bound enzym negat band chargetransf complex propos amino group aminobenzo pielectron benzen ring electron donor chargetransf complex posit amino group import chargetransf interact bind rate affin oaminobenzo enzym determin use absorpt chang caus modif electron state fad bound enzym caus format chargetransf complex oaminobenzo enzym differ paramet wavelength observ independ wavelength simplifi discuss experiment data obtain absorpt chang	D006223
acetylcholin synthesi sympathet human neuroblastoma	synthesi acetylcholin well catecholamin studi assay activ cholin acetyltransferas cha tyrosin hydroxylas tumor tissu cultur cell human neuroblastoma major neuroblastoma sympathet origin cha activ detect signific high level cultur cell five cell line human neuroblastoma cha activ high negat four line howev observ enzym activ chang signific longterm cultur cha assay use diagnost test neuroblastoma synthes acetylcholin futur studi neuroblastoma consid cholinerg activ	D009447
investig mechan central action kinin	effect kinin level norepinephrin dopamin serotonin metabolit normetanephrin homovanil acid 5hydroxyindoloacet acid brain tissu divid cerebellum corpus striatum cortex hippocampus hypothalamus medulla oblongata midbrain investig shown bradykinin dose mug decreas content norepinephrin corpus striatum midbrain cerebellum also decreas level dopamin corpus striatum increas level serotonin corpus striatum midbrain similar chang observ mukg kallikrein chang level investig neuromedi accompani chang level metabolit bradykinin dose mug decreas level normetanephrin corpus striatum hippocampus midbrain level homovanil acid corpus striatum increas level 5hydroxyindoloacet acid corpus striatum hippocampus also shown bradykinin increas norepinephrin uptak blood platelet level platelet low releas absorb norepinephrin medium level norepinephrin higher result confirm exist interact kinin neuromedi central nervous system	D007029
new find human prolactin	sinc prolactin hprl occur separ pituitari hormon man paper discuss result mechan involv regul hprl secret number factor lead increas hprl secret name clinic relev hprl inhibit substanc ldopa 2bralphaergocryptin mention influenc hprl pregnanc lactat period describ also regul effect hprl hormonedepend breast tumor	D001943
experi incompat matern donor bone marrow transplant	marrow transplant aplast anemia leukemia general limit sibl histocompat serolog lymphocyt determin mlc loci hla system studi three male patient two aplast anemia one acut myelogen leukemia receiv transplant histoincompat mother mlc studi donor recipi show vari degre stimul definit engraft occur one patient transient engraft anoth engraft third patient could evalu patient sustain engraft clinic evid sever graft versus host diseas gvhd howev substanti histolog find preliminari studi suggest mlc incompat may indic risk gvhd bone marrow reject effect control gvhd accomplish marrow transplant mlcreactiv individu may becom feasibl	D015470
nacetylbetaglucosaminidas activ hydatidiform mole	nacetylbetaglucosaminidas activ hydatidiform mole twofold higher fullterm placenta qualit enzym two tissu similar respect valu optima enzym also contain new isoenzym form detect polyacrylamid gel electrophoresi howev molar enzym suscept heat denatur presum due presenc higher level heatlabil isoenzym form tissu data also present incic placenta sourc nacetylbetaglucosaminidas activ matern serum	D006828
hormon product ovarian carcinoma histochem approach stroma reaction	enzymat activ stromal cell easc differ ovarian tumor concern hormon product case ovarian tumor investig differ histochem method distribut lactateand glucose6phosphatedehydrogenas investig plaimetr measurementeasc found benign ovarian tumor malign found exclus ovarian tumor complet absent metastas incid depend histolog type tumor regard untreat ovarian carcinoma contain easc cell cover aerea easc occur high percentag menopaus reduc chemotherapi radioat incid easc ovarian tumor relat postmenopaus bleed glandularcyst endometrium notic connect easc posit relat quantiti easc incid bleedingeasc character strong nadpdependentdehydrogenasereact reaction lactat malatedehydrogenas alcalin phosphatas apart cell uniform seem enzymat activ fibrocyt first step thecalik cell lutein final fill cholesterol histochemistri easc comparison steroidproduc tissu make possibl cell estrogen seldom also androgen activ	D010051
renal tubular acidosi reninaldosteron system illustr case pronounc hypokalemia		D034721
monoamin metabol human brain	norepinephrin dopamin tyrosin hydroxylas catecholomethyltransferas comt monoamin oxidas mao level measur human brain tissu obtain autopsi seri patient die various medic accident caus nine follow brain area studi globus pallidus thalamus hypothalamus hippocampus substantia nigra floor fourth ventricl orbit cortex caudat nucleus mammillari bodi enzym activ correl posit age brain area mao benzylamin tryptamin substrat consist pattern correl found comt mean mao activ signific higher women men increas brain mao activ late childhood adolesc data consist previous evid suggest age sex import determin amin metabol human central nervous system	D007029
acutephas reactant protein profil aid monitor larg bowel cancer cea serum enzym	profil acutephas reactant protein aprp haptoglobin hpt alpha1 antitrypsin aat alpha1 acid glycoprotein agp prealbumin palb studi evolut bowel cancer serial measur aprp add inform obtain measur level cea hepat enzym monitor postop patient consider stabil profil given individu health rise aat agp associ metastas high level hpt may suggest involv bowel wall recurr cancer palb level tend reflect nutrit status discrimin function base log cea aat agp preoper blood level consider improv predict valu attain use cea level alon	D009362
betahexosaminidas isozym human colon carcinoma	isoelectr focus crude extract demonstr human colon carcinoma contain higher proport betahexosaminidas betahexosaminidas normal human colon mucosa contain higher proport form enzym studi isol isozym show betahexosaminidas stabl heat activ low betahexosaminidas kinet studi reveal form betahexosaminidas essenti vmax pnitrophenylnacetylbetadglucosaminid	D003110
hepat microsom nglucuronid nucleic acid bind nhydroxi arylamin relat urinari bladder carcinogenesi	uridin 5diphosphoglucuron acidfortifi hepat microsom dog rat human rapid metabol 3hnhydroxy2naphthylamin nho2na watersolubl product yield parent nhydroxi amin upon treatment betaglucuronidas metabolit identifi nbeta1glucosiduronylnhydroxy2naphthylamin ultraviolet infrar mass spectral analys glucuronid nitron deriv incub nhydroxy1naphthylamin nho1na nhydroxy4aminobiphenyl nhoabp nhydroxi deriv 2aminofluoren 4aminoazobenzen nacetyl2aminofluoren uridin 5diphosphoglucuron acidfortifi hepat microsom also yield watersolubl product betaglucuronidas treatment releas 3hnho1na 3hnhoabp conjug tritiat etherextract deriv nho1na nho2na nhoabp glucuronid nhydroxi arylamin relat stabl nonreact near neutral nglucuronid nho2na presum nglucuronid nho1na nhoabp rapid hydrolyz nhydroxi arylamin convert reactiv deriv capabl bind coval nucleic acid data support concept arylamin bladder carcinogen noxid nglucuronid liver nglucuronid transport urinari bladder hydrolysi glucuronid nhydroxi arylamin convers latter deriv high reactiv electrophil arylnitrenium ion normal acid urin dog human may critic reaction tumor induct urinari bladder	D009369
impair enzym induct glucocorticoid zajdela hepatoma cell	wherea glucocorticoid induc tat trp gpt liver tat htc cell hormon effect synthesi enzym found zajdela hepatoma cell grown vivo ascit tumor vitro layer cultur although cell remain uninduc hormon penetr normal strong decreas specif bind cytosol nuclear protein hormon observ impair level hormon receptor could account noninduc enzym synthesi zhc cell	D006528
comparison vitro convers estradiol17 beta estron normal neoplast human breast tissu	specif activ betahydroxysteroid dehydrogenas betahsd measur tissu specimen human femal breast cancer addit nonmalign tissu specimen obtain case cancerbear breast case nonmalign tissu show greater convers estradiol17 beta estron neoplast tissu normal human breast tissu premenopaus women specif enzym activ depend phase menstrual cycl highest valu betahsd activ found earli secretori phase determin intracellular distribut betahsd purifi microsom mitochondria peroxysom lysosom nuclei cytosol fraction prepar puriti fraction monitor marker enzym found betahsd main locat mitochondria microsom furthermor could demonstr microsom enzym bound tight membran endoplasm reticulum mitochondri betahsd main associ outer membran organell kinet paramet kmvalu coenzym requir maxim veloc cytoplasm nuclear mitochondri microsom betahsd normal neoplast human mammari tissu compar maxim veloc highest enzym prepar normal mammari tissu obtain premenopaus women earli secretori phase kmvalu wrere near ident normal neoplast mammari tissu prepar approx nad effici nadp cofactor convers estradiol estron optimum temperatur approxim degre optimum reduct estron optimum sulphydryl group shown essenti catalysi	D001943
alveolar pco2 exceed pulmonari endcapillari co2 yes	christian bohr observ alveolar pco2 could exceed arteri pco2 high level co2 present inspir air propos co2 could secret lung hypothesi dismiss due experiment error howev recent phenomenon rediscov use modern techniqu possibl explan phenomenon may involv coupl diffus chemic reaction hco3 co2 vicin negat charg capillari wall caus pco2 higher near wall bulk phase capillari blood alveolar pco2 relat pco2 near wall rather bulk phase pco2 charg membran hypothes explain phenomenon co2 secret cellular mechan physic chemic disequilibrium within capillari maintain blood flow capillari	D002282
alveolar pco2 exceed pulmonari endcapillari co2	exchang chemic reaction co2 within blood complet transit time alveolar capillari theoret alveolar pco2 cannot exact equal endcapillari blood pco2 howev practic matter technic error determin alveolar peripher arteri pco2 larg comparison differ pulmonari arteri pco2 pulmonari venous pco2 owe larg effect solubl co2 blood reason alon differ alveolar endcapillari pco2 neglect hypothet mechan origin propos gurtner song farhi product alveolar pco2 greater endcapillari pco2 rebreath depend exist radial gradient hco3 capillari blood near wall appear unlik would requir signific separ charg ion larg proport capillari length larg proport blood transit time would requir larg radial gradient pco2 within blood thermodynam ground would turn requir unreason amount energi maintain	D002282
role prolactin carcinogenesi		D063646
stabil drink surfac water nine virus speci differ genera author transl	stabil nine virus aujeszki sindbi vesicular stomat newcastl diseas vaccinia fmd hcc reo teschen virus drink surfac water investig compar temperatur degre well influenc water factor like season differ temperatur valu hard sort water result summar follow temperatur degre major virus remain stabil natur water astonish long time start virus concentr infecti unit per teschen vaccinia reo hcc virus could most demonstr water longer day fmd aujeszki vesicular stomat sindbi virus day averag degre stabil virus investig decreas water name turn base result assum natur condit low virus content particl labil virus toga herp rhabdo labil picorna remain infecti water day import water contamin resist virus like paramyxo may keep infecti week stabil virus entero reo adeno pox virus sever week month factor temperatur hard sort waterwithin natur differ rangeon temperatur case less resist virus show signific influenc virus stabil water	D006528
renin aldosteron secret pheochromocytoma effect chronic alphaadrenerg receptor blockad	patient suffer pheochromocytoma character exclus almost exclus excess norepinephrin show one patient moder increas two patient renin aldosteron secret three patient concomit distinct hypersecret epinephrin renin releas aldosteron secret except one patient mark enhanc similar result obtain patient excess norepinephrin dopamin secret renin releas mark reduc patient preoper longterm alphaadrenerg receptor blockad except one patient increas renin aldosteron secret abolish result indic augment renin releas depend ratio differ catecholamin secret pheochromocytoma differ effet stimul betaadrenerg receptor even presenc excess catecholamin secret evid renin secret predomin mediat beta receptor rather renal vascular alphaadrenerg receptor normal catecholamineinduc enhanc renin releas patient pheochromocytoma chronic alphaadrenerg receptor blockad support assumpt alpha adrenerg block agent inhibit renin secret distal blockad specif adrenerg receptor howev contrari betaadrenerg blockad circadian rhythm renin releas seem remain intact alphaadrenerg blockad	D010673
inhibitor lasparagin synthetas vitro	systemat search made inhibitor lasparagin synthetas lglutamin hydrolyz leukemia 5178yar rodent neoplasm resist oncolyt enzym lasparaginas class chemic examin search includ substrat product analog agent capabl react sulfhydryl function varieti modifi whose mechan interact protein known general antagonist lglutamin thiol reagent prove effect inhibitor lasparagin synthetas tumor sourc within group certain structur prerequisit inhibit report attempt correl oncolyt potenc enzymeinhibitori potenc unsucces	D007938
activ distribut gammaglutamyl transpeptidas ygt human foetal organ	activ distribut ygt investig number organ human foetus age week post menstruationem period enzym activ increas kidney pancrea thymus decreas small intestin trend could establish liver although activ high lung spleen brain adren ygt either detect low level could demonstr possibl relationship ygt activ human tumour enzym level correspond foetal organ discuss	D010190
effect acetylsalicyl alkalin acid secret electrogen properti isol gastric mucosa	effect acetylsalicyl asa vitro secretori electr properti necturus rana temporaria gastric mucosa studi gastric antrum alkalin lumin surfac fundus like acidificaiton alkalin occur simultan net secret due domin one process histamin receptor antagonist metiamid use inhibit acid secret studi fundic alkalin rana temporaria submucos applic asa min mark reduc alkalin antrum frog fundus follow remov asa partial recoveri secret drug caus slight inhibt spontan acid secret necturus fundus histaminestimul acid secret frog fundus follow salicyl remov rate acid secret increas higher level administr tissu small flux asa across mucosa greatest acid secret frog fundus 438mumol cm2 min1 least antrum mumol cm2 min1 esposur gastric mucosa asa general associ fall transmucos electr potenti differ shortcircuit current togeth increas electr resist propos greater sensit alkalin asa respons appar increas rate acid secret occur	D013274
bioflavonoid regul atpas hexokinas activ ehrlich ascit cell mitochondria	mitochondri atpas ehrlich ascit cell mitochondria inhibit dglucos physiolog concentr atp generat adp mitochondri bound hexokinas seem reason dglucos inhibitori effect revers inhibitori effect adp ehrlich ascit cell mitochondria atpas atpregener system achiev dissoci mitochondri bound hexokinas mitochondria elimin inhibitori effect dglucos rebind hexokinas mitochondria regener dglucos inhibitori effect ehrlich ascit cell mitochondria atpas bioflavonoid quercetin inhibit mitochondri hexokinas activ chang mitochondri atpas activ isol ehrlich ascit tumor cell mitochondria inhibitori effect bioflavonoid mitochondri bound hexokinas activ shown dissoci ascit tumor cell mitochondria seem associ regulatori rather catalit site enzym	D002286
interact fever protein normal serum protein febril cancer patient	analyz cation discontinu electrophoresi ureacontain polyacrylamid gel plasma serum febril individu contain trace quanitit five protein band recogniz blood normal individu protein appear disappear parallel sequenti sampl cerebrospin fluid febril nonfebril individu contain protein band electrophoret ident one protein sinc trace protein migrat ureacontain polyacrylamid gel electrophoresi molecular size less equal to30000 dalton absenc cerebrospin fluid impli exist vivo interact serum protein nondissoci condit four band appear circul physic interact one anoth molecular siev chromatographi neutral lipidfre sera trace protein approxim molecular size dalton lipem sera molecular weight larger equal to200000 dalton behavior gel filtrat ionexchang chromatographi exclud extens interact follow immunoglobulin immunoglobulin alpha2macroglobulin haptoglobin albumin interact serum protein reduc high concentr urea low mechan respons observ proteinprotein associ would appear includ electrostat attract hydrogen bond weak hydrophob interact	D009369
hypertherm effect exponenti plateau ascit tumor cell vitro depend environment ph1		D009369
local hypophysiotrop neurohormon assay section various brain area	result studi local hypothalam hypophysiotrop factor base direct determin section nuclear punch describ lutein hormonereleas hormon found high concentr median eminencearcu nucleus complex lower concentr mediobas zone preoptic area addit hypothalam site present four periventricular organ especi organum vasculosum lamina terminali thyrotropin releas hormon widespread distribut high concentr median emin arcuat nucleus dorsomedi nucleus anterior part ventromedi nucleus lower concentr sever structur hypothalamus preoptic area septum low measur quantiti found structur brain somatostatin also present structur central nervous system highest concentr median emin arcuat nucleus ventromedi nucleus periventricular nucleus indic ventromedi nucleus immedi vicin contain growth hormon releas factor prolactin releas activ present median emin mediobas part anterior hypothalamus wherea prolactin inhibitori activ dorsolater part anterior hypothalamus andor preoptic area	D007029
divers effect 5bromodeoxyuridin enzym activ cultur h35 hepatoma cell	reuber h35 hepatoma cell grown medium contain 105m bromodeoxyuridin brdu incorpor dna cell growth rate unaffect brdu first two generat reduc effect brdu incorpor activ sever enzym rapid turnov rate examin test hypothesi synthesi enzym preferenti inhibit brdu tyrosin aminotransferas tat activ decreas within two generat wherea thymidin kinas activ remain control valu pep carboxykinas activ unchang first generat brducontain medium second activ increas least ornithin decarboxylas level decreas two generat presenc brdu appear simpl relationship turnov rate effect brdu enzym activ incorpor brdu found inhibit induct tat pep carboxykinas dexamethason enhanc inhibit cell growth steroid result discuss respect possibl mechan gene express develop normal neoplast cell	D006528
express hormon induc tyrosin transaminas normal host liver three morri hepatoma	cytoplasm tyrosin transaminas ltyrosin 2oxoglutar aminotransferas partial purifi normal host liver three morri hepatoma subsequ resolv electrophoresi polyacrylamid gel enzym activ detect histochem situ gel seven enzymat activ form detect normal liver presenc grow hepatoma alter signific express enzym one two four activ peak detect host liver anim high liverlik well poor least liverlik differenti hepatoma respect similar one four six peak detect respect high well poor differenti hepatoma	D006528
diagnosi hepat metastasi enzymat assay valu gammaglutamyltranspeptidas	variat serum enzym level studi patient suffer various type neoplasm hepat metastas absenc associ hepatobiliari pancreat disord gammaglutamyltranspeptidas would appear reliabl test case repres factor assess merit place prognost studi type neoplasia	D009362
blood serum peptidas patient ovarian carcinoma treat ledakrin	author observ chang activ leucin aminopeptidas 3411lap gammaglutamyl transpeptidas 2322ggtp coactiv acylas blood serum patient ovarian carcinoma without ascit treat ledakrin 1nitro93dimethylaminopropylamino acridin state activ lap ggtp increas treatment tumor progress level coactiv acylas increas slight treatment therefor determin enzym appear use monitor therapi ovarian carcinoma	D010051
new approach potenti test system drug prostat cancer	previous report test system base 5alphareductas 5alphara arginas activ steroid deposit anim prostat potenti use screen drug possibl effect cancer prostat recent concentr develop vivo vitro system may prove valu test drug system includ follow effect drug 5alphara activ human anim nonmalign human cancer prostat tissu organ cultur paramet necessari mainten optim 5alphara explant determin shown certain agent estramustin phosphat progesteron estradiol17beta inhibit 5alphara vitro condit point potenti use approach screen various cytostat agent addit 65zn deposit histolog androgen metabol tissu organ cultur determin addit paramet deposit 65zn rat dorsolater gland particular affect prolactin testosteron effect chemotherapeut agent deposit methotrex ccnu shown potent inhibitor 65zn deposit dorsolater gland paramet relat zinc metabol prostat investig demonstr receptor estrogen estradiol17beta diethylstilbestrol prostat baboon various paramet relat specif receptor establish develop standard approach facet report present public may prove sensit specif optim system afford opportun test various combin drug potenti use cancer prostat relat speed efficaci eas manipul	D011471
activ melanoma tyrosinas cyclic ampdepend protein kinas cellfre system		D008545
activ alkalin amphibian gastric fundic mucosa vitro	gastric fundic mucosa vitro four speci frog necturus secret hco3 steadyst rate microneqcm2h1 correspond maxim secret net alkalin quantit mucosa spontan rest secret mucosa inhibit histamin h2receptor antagonist snc hco3 secret inhibit dnp anoxia acetazolamid inhibit alkalin ad nutrient side lumin side carbachol dbcgmp stimul alkalin caus transient rise transmucos dbcamp without effect almost ident secret occur spontan antral mucosa insensit histamin occurr antral fundic mucosa suggest activ alkalin properti gastric surfac epitheli cell gastric alkalin may protect lumin surfac mucosa damag effect acid contribut continu remov ion gastric content	D013274
metabol respons total parenter nutrit cancer patient	order evalu metabol respons nutrit depriv cancer patient parenter nutrit metabol paramet includ glucos turnov oxid cori cycl activ measur eight patient shortterm day nutrit solut contain amino acid hyperton glucos parenter nutrit five patient essenti normal glucos turnov oxid cori cycl activ wherea three patient moder increas glucos turnov mark increas cori cycl activ respons parenter nutrit plasma glucos insulin venous lactat concentr increas free fatti acid decreas percentag respiratori co2 glucos oxid rate oxid increas co2 product increas wherea consumpt essenti unchang respiratori quotient rose greater endogen glucos product high basal cori cycl activ decreas total parenter nutrit judg clinic benefici five patient wherea one patient unchang deleteri respons includ moder lactic acidemia occur two three patient elev basal cori cycl activ	D009369
pituitari ovarian respons acut stimul lhrh normal anovulatori women	fsh estradiol progesteron respons acut stimul lhrh studi normal women ovulatori cycl initi follicular phase midfollicular phase late follicular phase two castrat women two hormon contracept two ovarian amenorrhea twelv central amenorrhea detect origin normal low basal gonadotrophin eleven anovulatori patient pseudomenstru two anorexia nervosa two pituitari amenorrhea woman receiv rapid inject microgram synthet lhrh serum level fsh estradiol progesteron determin radioimmunoassay sampl collect minut inject find signific rise estradiol progesteron level addit fsh elev normal women lack ovarian steroid respons castrat women ovarian amenorrhea suggest sourc steroid respons stimul extragonad signific differ respons four hormon lhrh women central amenorrhea comparison normal group great variabl result steroid respons presenc posit respons might correl sever andor prognosi disord point deserv studi anovulatori women pseudomenstru respons part normal particular progesteron respons	D010051
human thymidyl kinas purif character kinet behavior thymidyl kinas deriv chronic myelocyt leukemia	thymidyl kinas deriv blast cell human chronic myelocyt leukemia purifi 2186fold near homogen mean alcohol precipit aluminacgamma gel fraction calcium phosphat gel fraction ultrafiltr affin column chromatographi molecular weight estim glycerol gradient centrifug enzym optim activ requir dival cation order catalyz reaction mg2 mn2 found preferenti dival cation activ energi estim kcalmol initi veloc studi suggest reaction follow sequenti mechan mg2 atp dtmp micromet enzym unstabl even degre presenc atp dtmp enzym maintain activ purin triphosph nucleosid found better phosphat donor pyrimidin triphosph nucleosid atp datp lower higher vmax gtp dgtp dtmp prefer phosphat receptor among monophosph nucleotid test dttp idutp compet substrat inhibit reaction respect	D015464
dihydrofol reductas resist sublin l1210 lymphoma purif affin chromatographi ultraviolet differ spectrophotometr circular dichroic studi		D008223
bile lysosom enzym characterist patholog signific various hepatobiliari disord	activ sever glycosidas betagalactosidas betaglucosidas nacetylbetaglucosaminidas demonstr human bile enzym activ increas time exclus bile salt small molecular compound sephadex g50 gel filtrat use 4methylumbelliferyl deriv substrat use measur bile enzym activ alter presenc bile pigment enzym characterist bile glycosidas determin optimum isoelectr point bile glycosidas activ also measur various hepatobiliari disord cholelithiasi cancer gallbladd acut hepat liver cirrhosi fatti liver glycosidas activ bile patient liver diseas well cholelithiasi general decreas isoelectr focus pattern biliari glycosidas similar specimen patient hepatobiliari disord compar normal	D005706
effect caerulein gammaglutamyl transpeptidas alkalin phosphatas duoden juic chronic pancreat	infus caerulein output gammaglutamyl transpeptidas biliari alkalin phosphatas signific increas chronic pancreat patient normal subject presenc gallbladd necessari observ effect caerulein relat discharg larg amount enzym diseas pancrea	D010190
lasparaginaseantileukemia agent	paper describ recent develop field biosynthesi lasparaginas mean various cultur purif column chromatographi inform catabolit repress lasparaginas metabol mycobacteria separ purif studi idea effect differ activ quaternari structur effect specif antibodi catalyt activ lasparaginas discuss materi show role lasparaginas acut lymphocyt leukemia	D054198
